|Articles|March 9, 2020
MYCAP CCX®: Cell Expansion of the Future
Author(s)Sartorius
-The MYCAP CCX system removes the need to perform transfers in a biosafety cabinet -Reduces the risk of contamination by eliminating significant nonaseptic procedures
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
FAQ: What You Need to Know About Agentic AI in Drug Discovery
2
Coya Raises $11.1 Million to Advance Immunomodulatory ALS Program
3
HHS Releases New Guidance on Lowering Prescription Drug Prices Through DTC Programs
4
AstraZeneca’s $15 Billion Investment Deepens China R&D and Manufacturing Footprint
5